Novel targets of therapy in asthma
ST Holgate - Current opinion in pulmonary medicine, 2009 - journals.lww.com
Current opinion in pulmonary medicine, 2009•journals.lww.com
What is becoming clear in filling the pipeline with new asthma therapies that treat the
underlying disease causes is the need for closer working between clinical academics and
industry to ensure that there is a rapid and sustained transfer of knowledge on novel targets
through to their validation, proof of concept studies and clinical trials.
underlying disease causes is the need for closer working between clinical academics and
industry to ensure that there is a rapid and sustained transfer of knowledge on novel targets
through to their validation, proof of concept studies and clinical trials.
Summary
What is becoming clear in filling the pipeline with new asthma therapies that treat the underlying disease causes is the need for closer working between clinical academics and industry to ensure that there is a rapid and sustained transfer of knowledge on novel targets through to their validation, proof of concept studies and clinical trials.
Lippincott Williams & Wilkins